{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T05:06:24Z","timestamp":1789707984914,"version":"4.0.1"},"reference-count":157,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["R01AT005076"],"award-info":[{"award-number":["R01AT005076"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R35GM145331"],"award-info":[{"award-number":["R35GM145331"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Dysregulated inflammation, characterized by the uncontrolled release of inflammatory mediators, is central to the pathogenesis of numerous inflammatory diseases, including acute sepsis and chronic rheumatoid arthritis (RA). Despite therapeutic advances in RA, limitations of current anti-inflammatory treatments\u2014such as broad immunosuppression and partial efficacy\u2014highlight an urgent need for novel interventions. This review critically examines the pathogenic roles of High Mobility Group Box 1 (HMGB1) and procathepsin-L (pCTS-L) in dysregulated inflammation, mediated by their interactions with Toll-like receptor 4 (TLR4) and the Receptor for Advanced Glycation End Products (RAGE). Crucially, we highlight the newly established HMGB1-pCTS-L axis, in which HMGB1 directly upregulates pCTS-L expression and release. This axis initiates a delayed yet sustained inflammatory loop, which may predominantly activate the more enduring non-canonical NF-\u03baB pathway. Furthermore, we explore the intricate role of tetranectin (TN), an endogenous HMGB1-binding protein, which inhibits HMGB1 release but paradoxically facilitates HMGB1-induced pyroptosis. Leveraging this complexity, we introduce the TN-derived P2\u20131 peptide as a highly specific inhibitor of the HMGB1-pCTS-L axis. This peptide binds HMGB1 to prevent its RAGE engagement and subsequent macrophage pyroptosis, without broadly suppressing initial inflammatory cascades. It also specifically inhibits HMGB1-induced pCTS-L expression and release, ameliorating both sepsis and RA even with delayed treatment. Its \u201cdisease-triggered\u201d mechanism, selectively targeting extracellular HMGB1 only at pathological sites, promises enhanced safety and precision. This review positions the HMGB1-pCTS-L axis as a critical and therapeutically tractable pathway, with HMGB1- and pCTS-L-inhibiting antibodies and mimetic peptides representing promising next-generation interventions for a spectrum of inflammatory diseases.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1843251","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:45:36Z","timestamp":1778215536000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Pharmacological intervention of the HMGB1-pCTS-L axis to ameliorate inflammatory diseases"],"prefix":"10.3389","volume":"17","author":[{"given":"Weiqiang","family":"Chen","sequence":"first","affiliation":[{"name":"Northwell, New Hyde Park, NY and Feinstein Institutes for Medical Research, Northwell Health","place":["Manhasset, NY, United States"]},{"name":"Departments of Emergency Medicine and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell","place":["Hempstead, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Li","sequence":"additional","affiliation":[{"name":"Northwell, New Hyde Park, NY and Feinstein Institutes for Medical Research, Northwell Health","place":["Manhasset, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Qiang","sequence":"additional","affiliation":[{"name":"Northwell, New Hyde Park, NY and Feinstein Institutes for Medical Research, Northwell Health","place":["Manhasset, NY, United States"]},{"name":"Departments of Emergency Medicine and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell","place":["Hempstead, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Lou","sequence":"additional","affiliation":[{"name":"Northwell, New Hyde Park, NY and Feinstein Institutes for Medical Research, Northwell Health","place":["Manhasset, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassie Shu","family":"Zhu","sequence":"additional","affiliation":[{"name":"Northwell, New Hyde Park, NY and Feinstein Institutes for Medical Research, Northwell Health","place":["Manhasset, NY, United States"]},{"name":"Departments of Emergency Medicine and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell","place":["Hempstead, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meihong","family":"Deng","sequence":"additional","affiliation":[{"name":"Northwell, New Hyde Park, NY and Feinstein Institutes for Medical Research, Northwell Health","place":["Manhasset, NY, United States"]},{"name":"Departments of Emergency Medicine and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell","place":["Hempstead, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haichao","family":"Wang","sequence":"additional","affiliation":[{"name":"Northwell, New Hyde Park, NY and Feinstein Institutes for Medical Research, Northwell Health","place":["Manhasset, NY, United States"]},{"name":"Departments of Emergency Medicine and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra\/Northwell","place":["Hempstead, NY, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3895437","article-title":"Passive immunization against cachectin\/tumor necrosis factor protects mice from lethal effect of endotoxin","volume":"229","author":"Beutler","year":"1985","journal-title":"Science"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/330662a0","article-title":"Anti-cachectin\/tnf monoclonal antibodies prevent septic shock during lethal bacteraemia","volume":"330","author":"Tracey","year":"1987","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v87.6.2095.bloodjournal8762095","article-title":"Biologic basis for interleukin-1 in disease","volume":"87","author":"Dinarello","year":"1996","journal-title":"Blood"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1126\/science.285.5425.248","article-title":"Hmg-1 as a late mediator of endotoxin lethality in mice","volume":"285","author":"Wang","year":"1999","journal-title":"Science"},{"key":"B5","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1073\/pnas.2434651100","article-title":"Reversing established sepsis with antagonists of endogenous high-mobility group box 1","volume":"101","author":"Yang","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf4313","article-title":"Identification of procathepsin l (pcts-l)-neutralizing monoclonal antibodies to treat potentially lethal sepsis","volume":"9","author":"Zhu","year":"2023","journal-title":"Sci Adv"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2023.2239495","article-title":"A two-decade journey in identifying high mobility group box 1 (hmgb1) and procathepsin l (pcts-l) as potential therapeutic targets for sepsis","volume":"27","author":"Li","year":"2023","journal-title":"Expert Opin Ther Targets"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(23)01525-8","article-title":"Rheumatoid arthritis","volume":"402","author":"Di Matteo","year":"2023","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(17)31491-5","article-title":"Novel treatment strategies in rheumatoid arthritis","volume":"389","author":"Burmester","year":"2017","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2009.181","article-title":"Anti-tnf biologic agents: still the therapy of choice for rheumatoid arthritis","volume":"5","author":"Taylor","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.19.1.163","article-title":"Anti-tnf alpha therapy of rheumatoid arthritis: what have we learned","volume":"19","author":"Feldmann","year":"2001","journal-title":"Annu Rev Immunol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(94)90628-9","article-title":"Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (ca2) versus placebo in rheumatoid arthritis","volume":"344","author":"Elliott","year":"1994","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1593342","article-title":"Value of animal sepsis research in navigating the translational labyrinth","volume":"16","author":"Wang","year":"2025","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00894-6","article-title":"The multifunctional protein hmgb1: 50 years of discovery","volume":"23","author":"Tang","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20052203","article-title":"Role of hmgb1 in apoptosis-mediated sepsis lethality","volume":"203","author":"Qin","year":"2006","journal-title":"J Exp Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2018.08.016","article-title":"The endotoxin delivery protein hmgb1 mediates caspase-11-dependent lethality in sepsis","volume":"49","author":"Deng","year":"2018","journal-title":"Immunity"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.0300-9475.2005.01534.x","article-title":"Rage is the major receptor for the proinflammatory activity of hmgb1 in rodent macrophages","volume":"61","author":"Kokkola","year":"2005","journal-title":"Scand J Immunol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1002\/art.11161","article-title":"Successful treatment of collagen-induced arthritis in mice and rats by targeting extracellular high mobility group box chromosomal protein 1 activity","volume":"48","author":"Kokkola","year":"2003","journal-title":"Arthritis Rheum"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/art.11028","article-title":"High mobility group box chromosomal protein 1, a dna binding cytokine, induces arthritis","volume":"48","author":"Pullerits","year":"2003","journal-title":"Arthritis Rheum"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2796.2003.01303.x","article-title":"Hmgb1 is a potent trigger of arthritis","volume":"255","author":"Andersson","year":"2004","journal-title":"J Intern Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2102034118","article-title":"Hmgb1 released from nociceptors mediates inflammation","volume":"118","author":"Yang","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-021-00841-9","article-title":"Lactate promotes macrophage hmgb1 lactylation, acetylation, and exosomal release in polymicrobial sepsis","volume":"29","author":"Yang","year":"2022","journal-title":"Cell Death Differ"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1316925111","article-title":"Jak\/stat1 signaling promotes hmgb1 hyperacetylation and nuclear translocation","volume":"111","author":"Lu","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.177.11.7889","article-title":"Nucleocytoplasmic shuttling of hmgb1 is regulated by phosphorylation that redirects it toward secretion","volume":"177","author":"Youn","year":"2006","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.7.3890","article-title":"Ifn-gamma induces high mobility group box 1 protein release partly through a tnf-dependent mechanism","volume":"170","author":"Rendon-Mitchell","year":"2003","journal-title":"J Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/embo-reports\/kvf198","article-title":"The nuclear protein hmgb1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway","volume":"3","author":"Gardella","year":"2002","journal-title":"EMBO Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/cdg516","article-title":"Monocytic cells hyperacetylate chromatin protein hmgb1 to redirect it towards secretion","volume":"22","author":"Bonaldi","year":"2003","journal-title":"EMBO J"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1002\/prca.201900119","article-title":"Lipopolysaccharide-regulated secretion of soluble and vesicle-based proteins from a panel of colorectal cancer cell lines","volume":"15","author":"Garcia de Durango","year":"2021","journal-title":"Proteomics Clin Appl"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2025.110866","article-title":"Mapping the intracellular hmgb1 interactome and alterations induced by toll-like receptor 4 activation","volume":"301","author":"Heinb\u00e4ck","year":"2025","journal-title":"J Biol Chem"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein hmgb1 by necrotic cells triggers inflammation","volume":"418","author":"Scaffidi","year":"2002","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","first-page":"4561","DOI":"10.1038\/s41467-020-18443-3","article-title":"Indirect regulation of hmgb1 release by gasdermin d","volume":"11","author":"Volchuk","year":"2020","journal-title":"Nat Commun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1126\/science.1240988","article-title":"Cytoplasmic lps activates caspase-11: implications in tlr4-independent endotoxic shock","volume":"341","author":"Hagar","year":"2013","journal-title":"Science"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.07.007","article-title":"Trif licenses caspase-11-dependent nlrp3 inflammasome activation by gram-negative bacteria","volume":"150","author":"Rathinam","year":"2012","journal-title":"Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2015.07.016","article-title":"Canonical inflammasomes drive ifn-\u03b3 to prime caspase-11 in defense against a cytosol-invasive bacterium","volume":"18","author":"Aachoui","year":"2015","journal-title":"Cell Host Microbe"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1002843","article-title":"Serum amyloid a activates the nlrp3 inflammasome via p2x7 receptor and a cathepsin b-sensitive pathway","volume":"186","author":"Niemi","year":"2011","journal-title":"J Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"64","DOI":"10.4049\/jimmunol.1100500","article-title":"Serum amyloid a activates the nlrp3 inflammasome and promotes th17 allergic asthma in mice","volume":"187","author":"Ather","year":"2011","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/s41598-018-37232-z","article-title":"Enhanced macrophage pannexin 1 expression and hemichannel activation exacerbates lethal experimental sepsis","volume":"9","author":"Chen","year":"2019","journal-title":"Sci Rep"},{"key":"B39","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41598-017-18452-1","article-title":"Connexin 43 hemichannel as a novel mediator of sterile and infectious inflammatory diseases","volume":"8","author":"Li","year":"2018","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1523306","article-title":"Connexin 43 and pannexin 1 hemichannels as endogenous regulators of innate immunity in sepsis","volume":"15","author":"Li","year":"2024","journal-title":"Front Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.108826","article-title":"Proteomics reveals distinct mechanisms regulating the release of cytokines and alarmins during pyroptosis","volume":"34","author":"Phulphagar","year":"2021","journal-title":"Cell Rep"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1003893107","article-title":"A critical cysteine is required for hmgb1 binding to toll-like receptor 4 and activation of macrophage cytokine release","volume":"107","author":"Yang","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00401.2005","article-title":"High mobility group box 1 protein interacts with multiple toll-like receptors","volume":"290","author":"Park","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1097\/01.shk.0000225404.51320.82","article-title":"Hmgb1 signals through toll-like receptor (tlr) 4 and tlr2","volume":"26","author":"Yu","year":"2006","journal-title":"Shock"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2009.00062","article-title":"Spermine protects mice against lethal sepsis partly by attenuating surrogate inflammatory markers","volume":"15","author":"Zhu","year":"2009","journal-title":"Mol Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.10.6573","article-title":"Hemorrhagic shock induces nad(p)h oxidase activation in neutrophils: role of hmgb1-tlr4 signaling","volume":"178","author":"Fan","year":"2007","journal-title":"J Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-05-1300","article-title":"Inflammation-promoting activity of hmgb1 on human microvascular endothelial cells","volume":"101","author":"Fiuza","year":"2003","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.113063","article-title":"Direct interaction of hmgb1 with sars-cov-2 facilitates its infection via rage-dependent endocytosis","volume":"28","author":"Jung","year":"2025","journal-title":"iScience"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2010.11.014","article-title":"Heparin changes the conformation of high-mobility group protein 1 and decreases its affinity toward receptor for advanced glycation endproducts in vitro","volume":"11","author":"Ling","year":"2011","journal-title":"Int Immunopharmacol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.43.25752","article-title":"The receptor for advanced glycation end products (rage) is a cellular binding site for amphoterin. mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system","volume":"270","author":"Hori","year":"1995","journal-title":"J Biol Chem"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1038\/ni1457","article-title":"Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by Hmgb1 and Rage","volume":"8","author":"Tian","year":"2007","journal-title":"Nat Immunol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature08512","article-title":"Hmgb proteins function as universal sentinels for nucleic-acid-mediated innate immune responses","volume":"462","author":"Yanai","year":"2009","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.supp.89.24","article-title":"A novel role for Hmgb1 in Tlr9-mediated inflammatory responses to Cpg-DNA","volume":"110","author":"Ivanov","year":"2007","journal-title":"Blood"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2014.40","article-title":"Macrophage endocytosis of high-mobility group box 1 triggers pyroptosis","volume":"21","author":"Xu","year":"2014","journal-title":"Cell Death Differ"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.5HI0316-128RR","article-title":"Frontline science: Hmgb1 induces neutrophil dysfunction in experimental sepsis and in patients who survive septic shock","volume":"101","author":"Gregoire","year":"2017","journal-title":"J Leukoc Biol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2012-0279oc","article-title":"Hmgb1 mediates hyperoxia-induced impairment of Pseudomonas aeruginosa clearance and inflammatory lung injury in mice","volume":"48","author":"Patel","year":"2012","journal-title":"Am J Respir Cell Mol Biol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092220","article-title":"Endogenous regulation and pharmacological modulation of sepsis-induced Hmgb1 release and action: An updated review","volume":"10","author":"Zhu","year":"2021","journal-title":"Cells"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103521","article-title":"Ros anchor Pamps-mediated extracellular Hmgb1 self-association and its dimerization enhances pro-inflammatory signaling","volume":"80","author":"Kwak","year":"2025","journal-title":"Redox Biol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1523\/jneurosci.2439-14.2015","article-title":"Damp signaling is a key pathway inducing immune modulation after brain injury","volume":"35","author":"Liesz","year":"2015","journal-title":"J Neurosci"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/cells10071646","article-title":"Systemic T cell exhaustion dynamics is linked to early high mobility group box protein 1 (Hmgb1) driven hyper-inflammation in a polytrauma rat model","volume":"10","author":"Muire","year":"2021","journal-title":"Cells"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1097\/cji.0b013e3181dcd111","article-title":"Preconditioning with high mobility group box 1 (Hmgb1) induces lipoteichoic acid (Lta) tolerance","volume":"33","author":"Robert","year":"2010","journal-title":"J Immunother"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0108030","article-title":"Preconditioning with high mobility group box 1 (Hmgb1) induces lipopolysaccharide (Lps) tolerance","volume":"84","author":"Aneja","year":"2008","journal-title":"J Leukoc Biol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2025.102926","article-title":"Redox-sensitive high mobility group box 1 (Hmgb1) is a multifunctional regulator of cellular senescence, inflammation, and immunosuppression: Impact on the aging process","volume":"113","author":"Salminen","year":"2026","journal-title":"Ageing Res Rev"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxs051","article-title":"Hmgb1 conveys immunosuppressive characteristics on regulatory and conventional T cells","volume":"24","author":"Wild","year":"2012","journal-title":"Int Immunol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.abb.2009.09.016","article-title":"Effect of high mobility group box-1 protein on apoptosis of peritoneal macrophages","volume":"492","author":"Zhu","year":"2009","journal-title":"Arch Biochem Biophys"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2024.08.015","article-title":"Dual alarmin-receptor-specific targeting peptide systems for treatment of sepsis","volume":"14","author":"Mun","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1540908","article-title":"Identification of a multiple Damp scavenger mimicking the Damp-binding site of Tlr4 to ameliorate lethal sepsis","volume":"16","author":"Murao","year":"2025","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.10.2106117","article-title":"Hmgb1 as a late mediator of lethal systemic inflammation","volume":"164","author":"Wang","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2009.11.003","article-title":"The role of Hmgb1 in the pathogenesis of rheumatic disease","volume":"1799","author":"Andersson","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"B70","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrrheum.2011.222","article-title":"Hmgb1: A multifunctional alarmin driving autoimmune and inflammatory disease","volume":"8","author":"Harris","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1002\/art.10859","article-title":"High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine","volume":"48","author":"Taniguchi","year":"2003","journal-title":"Arthritis Rheum"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/art.10540","article-title":"High mobility group box chromosomal protein 1: A novel proinflammatory mediator in synovitis","volume":"46","author":"Kokkola","year":"2002","journal-title":"Arthritis Rheum"},{"key":"B73","doi-asserted-by":"publisher","first-page":"R35","DOI":"10.1186\/ar2155","article-title":"Morphological characterization of intra-articular Hmgb1 expression during the course of collagen-induced arthritis","volume":"9","author":"Palmblad","year":"2007","journal-title":"Arthritis Res Ther"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/nri1594","article-title":"High-mobility group box 1 protein (Hmgb1): Nuclear weapon in the immune arsenal","volume":"5","author":"Lotze","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.123361","article-title":"Pain in rheumatoid arthritis: Emerging role of high mobility group box 1 protein-Hmgb1","volume":"362","author":"Krishna","year":"2025","journal-title":"Life Sci"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/s0304-3959(01)00354-2","article-title":"A new model of sciatic inflammatory neuritis (Sin): Induction of unilateral and bilateral mechanical allodynia following acute unilateral peri-sciatic immune activation in rats","volume":"94","author":"Chacur","year":"2001","journal-title":"Pain"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2010.00264","article-title":"Monoclonal anti-Hmgb1 (high mobility group box chromosomal protein 1) antibody protection in two experimental arthritis models","volume":"17","author":"Schierbeck","year":"2011","journal-title":"Mol Med"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1172\/jci113497","article-title":"Complete nucleotide and deduced amino acid sequences of human and murine preprocathepsin L. An abundant transcript induced by transformation of fibroblasts","volume":"81","author":"Joseph","year":"1988","journal-title":"J Clin Invest"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1016\/s0021-9258(18)54038-2","article-title":"Cloning, genomic organization, and chromosomal localization of human cathepsin L","volume":"268","author":"Chauhan","year":"1993","journal-title":"J Biol Chem"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065x.1988.tb00777.x","article-title":"The role of intracellular acidification in antigen processing","volume":"106","author":"McCoy","year":"1988","journal-title":"Immunol Rev"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20020762","article-title":"Invariant chain controls the activity of extracellular cathepsin L","volume":"196","author":"Fiebiger","year":"2002","journal-title":"J Exp Med"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/36.7.735","article-title":"Selective induction of the secretion of cathepsins B and L by cytokines in synovial fibroblast-like cells","volume":"36","author":"Lemaire","year":"1997","journal-title":"Br J Rheumatol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(95)00287-j","article-title":"Gamma-interferon causes a selective induction of the lysosomal proteases, cathepsins B and L, in macrophages","volume":"363","author":"Lah","year":"1995","journal-title":"FEBS Lett"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1320808110","article-title":"Conditional ablation of Hmgb1 in mice reveals its protective function against endotoxemia and bacterial infection","volume":"110","author":"Yanai","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.12.015","article-title":"Intracellular Hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice","volume":"146","author":"Kang","year":"2014","journal-title":"Gastroenterology"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1368448","article-title":"Therapeutic potential of procathepsin L-inhibiting and progesterone-entrapping dimethyl-B-cyclodextrin nanoparticles in treating experimental sepsis","volume":"15","author":"Qiang","year":"2024","journal-title":"Front Immunol"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24108649","article-title":"Development of procathepsin L (Pcts-L)-inhibiting lanosterol-carrying liposome nanoparticles to treat lethal sepsis","volume":"24","author":"Chen","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(93)92627-6","article-title":"Pathogenesis of rheumatoid arthritis","volume":"341","author":"Sewell","year":"1993","journal-title":"Lancet"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(17)31472-1","article-title":"Pathogenetic insights from the treatment of rheumatoid arthritis","volume":"389","author":"McInnes","year":"2017","journal-title":"Lancet"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152329","article-title":"Predicting best treatment in rheumatoid arthritis","author":"Lewis","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"B91","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1080\/14740338.2020.1763299","article-title":"Concerns about the safety of anti-Tnf agents when treating rheumatic diseases","volume":"19","author":"Atzeni","year":"2020","journal-title":"Expert Opin Drug Saf"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380714","article-title":"Comparative analysis of cathepsin L, cathepsin D, and collagenase messenger RNA expression in synovial tissues of patients with rheumatoid arthritis and osteoarthritis, by in situ hybridization","volume":"38","author":"Keyszer","year":"1995","journal-title":"Arthritis Rheum"},{"key":"B93","article-title":"Elevation of cathepsin L levels in the synovial lining of rabbits with antigen-induced arthritis","volume":"69","author":"Etherington","year":"1988","journal-title":"Br J Exp Pathol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/art.1780400316","article-title":"Macrophage cathepsin L, a factor in the erosion of subchondral bone in rheumatoid arthritis","volume":"40","author":"Iwata","year":"1997","journal-title":"Arthritis Rheum"},{"key":"B95","first-page":"61","article-title":"Cathepsins B and L in synovial fluids from patients with rheumatoid arthritis and the effect of cathepsin B on the activation of pro-urokinase","volume":"47","author":"Ikeda","year":"2000","journal-title":"J Med Invest"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.3109\/03009742.2014.882979","article-title":"Circulating plasma levels of cathepsin S and L are not associated with disease severity in patients with rheumatoid arthritis","volume":"43","author":"Ruge","year":"2014","journal-title":"Scand J Rheumatol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu486","article-title":"Cathepsin S and cathepsin L in serum and synovial fluid in rheumatoid arthritis with and without autoantibodies","volume":"54","author":"Weitoft","year":"2015","journal-title":"Rheumatol (Oxford)"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-012-0495-x","article-title":"Decreased arthritis severity in cathepsin L-deficient mice is attributed to an impaired T helper cell compartment","volume":"61","author":"Schurigt","year":"2012","journal-title":"Inflammation Res"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302265","article-title":"Targeting cathepsin L (Cl) by specific ribozymes decreases Cl protein synthesis and cartilage destruction in rheumatoid arthritis","volume":"11","author":"Schedel","year":"2004","journal-title":"Gene Ther"},{"key":"B100","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40779-026-00686-8","article-title":"Repurposing a detrimental antibody epitope as targeted therapeutics for sepsis and rheumatoid arthritis","volume":"12","author":"Chen","year":"2025","journal-title":"Mil Med Res"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1764230","article-title":"A comparative analysis of Hmgb1 and Pcts-L immunomodulatory properties in human peripheral blood mononuclear cells","volume":"17","author":"Lou","year":"2026","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.4.565","article-title":"High mobility group 1 protein (Hmg-1) stimulates proinflammatory cytokine synthesis in human monocytes","volume":"192","author":"Andersson","year":"2000","journal-title":"J Exp Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.52","article-title":"The non-canonical Nf-Kb pathway in immunity and inflammation","volume":"17","author":"Sun","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00613","article-title":"Nuclear factor-kappab in autoimmunity: Man and mouse","volume":"9","author":"Miraghazadeh","year":"2018","journal-title":"Front Immunol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting Nf-Kb pathway for the therapy of diseases: Mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1588486","article-title":"The path less traveled: The non-canonical Nf-Kb pathway in systemic lupus erythematosus","volume":"16","author":"Montano","year":"2025","journal-title":"Front Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1102454","article-title":"The Ikk\u03b1-dependent Nf-Kb p52\/Relb noncanonical pathway is essential to sustain a Cxcl12 autocrine loop in cells migrating in response to Hmgb1","volume":"188","author":"Kew","year":"2012","journal-title":"J Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2015.10.009","article-title":"Caspase-11 requires the Pannexin-1 channel and the purinergic P2x7 pore to mediate pyroptosis and endotoxic shock","volume":"43","author":"Yang","year":"2015","journal-title":"Immunity"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/nature10558","article-title":"Non-canonical inflammasome activation targets caspase-11","volume":"479","author":"Kayagaki","year":"2011","journal-title":"Nature"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1038\/nm1124","article-title":"Cholinergic agonists inhibit Hmgb1 release and improve survival in experimental sepsis","volume":"10","author":"Wang","year":"2004","journal-title":"Nat Med"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvt275","article-title":"Thrombomodulin's lectin-like domain reduces myocardial damage by interfering with Hmgb1-mediated Tlr2 signalling","volume":"101","author":"Herzog","year":"2014","journal-title":"Cardiovasc Res"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2017.4308","article-title":"Evaluation of the effect of recombinant thrombomodulin on a lipopolysaccharide-induced murine sepsis model","volume":"13","author":"Takehara","year":"2017","journal-title":"Exp Ther Med"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1172\/jci22782","article-title":"The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism","volume":"115","author":"Abeyama","year":"2005","journal-title":"J Clin Invest"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.4049\/immunohorizons.2200094","article-title":"Recombinant human thrombomodulin reduces mortality and acute lung injury caused by septic peritonitis in rats","volume":"7","author":"Kono","year":"2023","journal-title":"Immunohorizons"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2021.155723","article-title":"Recombinant thrombomodulin attenuates hyper-inflammation and glycocalyx damage in a murine model of Streptococcus pneumoniae-induced sepsis","volume":"149","author":"Watanabe","year":"2022","journal-title":"Cytokine"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1159\/000438507","article-title":"Recombinant thrombomodulin modulates murine colitis possibly via high-mobility group box 1 protein inhibition","volume":"92","author":"Ueda","year":"2015","journal-title":"Digestion"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.85375","article-title":"Identification of Cd163 as an antiinflammatory receptor for Hmgb1-haptoglobin complexes","volume":"1","author":"Yang","year":"2016","journal-title":"JCI Insight"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-719757","article-title":"C1q and Hmgb1 reciprocally regulate human macrophage polarization","volume":"128","author":"Son","year":"2016","journal-title":"Blood"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1907490116","article-title":"Hmgb1-C1q complexes regulate macrophage function by switching between leukotriene and specialized proresolving mediator biosynthesis","volume":"116","author":"Liu","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01772-6","article-title":"Lupus autoantibodies initiate neuroinflammation sustained by continuous Hmgb1:Rage signaling and reversed by increased Lair-1 expression","volume":"25","author":"Carroll","year":"2024","journal-title":"Nat Immunol"},{"key":"B121","doi-asserted-by":"publisher","first-page":"12\/539","DOI":"10.1126\/scitranslmed.aaz3833","article-title":"Identification of tetranectin-targeting monoclonal antibodies to treat potentially lethal sepsis","volume":"12","author":"Chen","year":"2020","journal-title":"Sci Transl Med"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e15224","article-title":"Quantitative proteomics analysis of Covid-19 patients: Fetuin-a and tetranectin as potential modulators of innate immune responses","volume":"9","author":"Alghanem","year":"2023","journal-title":"Heliyon"},{"key":"B123","article-title":"Plasma tetranectin levels and disease activity in patients with rheumatoid arthritis","volume":"24","author":"Kamper","year":"1997","journal-title":"J Rheumatol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1007\/bf01451013","article-title":"Comparative study of tetranectin levels in serum and synovial fluid of patients with rheumatoid arthritis, seronegative spondylarthritis and osteoarthritis","volume":"17","author":"Kamper","year":"1998","journal-title":"Clin Rheumatol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/srep17632","article-title":"Tetranectin as a potential biomarker for stable coronary artery disease","volume":"5","author":"Chen","year":"2015","journal-title":"Sci Rep"},{"key":"B126","doi-asserted-by":"publisher","first-page":"7507","DOI":"10.1038\/s41598-020-64558-4","article-title":"Tetranectin, a potential novel diagnostic biomarker of heart failure, is expressed within the myocardium and associates with cardiac fibrosis","volume":"10","author":"McDonald","year":"2020","journal-title":"Sci Rep"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1007\/s00380-023-02277-2","article-title":"Tetranectin as a potential novel prognostic biomarker in anthracycline-related cardiac dysfunction","volume":"38","author":"Kopeva","year":"2023","journal-title":"Heart Vessels"},{"key":"B128","doi-asserted-by":"publisher","first-page":"11689","DOI":"10.1038\/s41467-025-66763-z","article-title":"Risk factors for mortality in patients with kidney failure on hemodialysis identified by proteomic analysis of Cric and Pace studies","volume":"16","author":"Ren","year":"2025","journal-title":"Nat Commun"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq1799","article-title":"The adipocyte-enriched secretory protein tetranectin exacerbates type 2 diabetes by inhibiting insulin secretion from B cells","volume":"8","author":"Liu","year":"2022","journal-title":"Sci Adv"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S262605","article-title":"Time to develop therapeutic antibodies against harmless proteins colluding with sepsis mediators","volume":"9","author":"Li","year":"2020","journal-title":"Immunotargets Ther"},{"key":"B131","doi-asserted-by":"publisher","first-page":"12\/539","DOI":"10.1126\/scitranslmed.abb2575","article-title":"Breaking the bond between tetranectin and Hmgb1 in sepsis","volume":"12","author":"Paterson","year":"2020","journal-title":"Sci Transl Med"},{"key":"B132","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/d41573-020-00077-1","article-title":"Antibody intervention rescues mice from sepsis","volume":"19","author":"Crunkhorn","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.113473","article-title":"Pathogenic epitope-specific monoclonal antibody-based immunoassay for accurate diagnosis and monitoring of tetranectin in sepsis","volume":"143","author":"Wang","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.3390\/biom15081100","article-title":"Identification of two critical contact residues in a pathogenic epitope from tetranectin for monoclonal antibody binding and preparation of single-chain variable fragments","volume":"15","author":"Wang","year":"2025","journal-title":"Biomolecules"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.44.29241","article-title":"The plasminogen binding site of the C-type lectin tetranectin is located in the carbohydrate recognition domain, and binding is sensitive to both calcium and lysine","volume":"273","author":"Graversen","year":"1998","journal-title":"J Biol Chem"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1021\/bi000155j","article-title":"Tetranectin-binding site on plasminogen kringle 4 involves the lysine-binding pocket and at least one additional amino acid residue","volume":"39","author":"Graversen","year":"2000","journal-title":"Biochemistry"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291x(89)92616-8","article-title":"Functional analogy between lipoprotein(a) and plasminogen in the binding to the kringle 4 binding protein, tetranectin","volume":"161","author":"Kluft","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1046\/j.1432-1033.2003.03549.x","article-title":"Tetranectin binds hepatocyte growth factor and tissue-type plasminogen activator","volume":"270","author":"Westergaard","year":"2003","journal-title":"Eur J Biochem"},{"key":"B139","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1084\/jem.20141318","article-title":"Md-2 is required for disulfide Hmgb1-dependent Tlr4 signaling","volume":"212","author":"Yang","year":"2015","journal-title":"J Exp Med"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118088","article-title":"Cryo-Em structure of Hmgb1-Rage complex and its inhibitory effect on lung cancer","volume":"187","author":"Kim","year":"2025","journal-title":"BioMed Pharmacother"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200402-188oc","article-title":"Contributions of high mobility group box protein in experimental and clinical acute lung injury","volume":"170","author":"Ueno","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1097\/01.ccm.0000129488.54282.1a","article-title":"Evaluation of protein C and other biomarkers as predictors of mortality in a rat cecal ligation and puncture model of sepsis","volume":"32","author":"Heuer","year":"2004","journal-title":"Crit Care Med"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001153","article-title":"A major ingredient of green tea rescues mice from lethal sepsis partly by inhibiting Hmgb1","volume":"2","author":"Li","year":"2007","journal-title":"PloS One"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1569632","article-title":"Hmgb1: New biomarker and therapeutic target of autoimmune and autoinflammatory skin diseases","volume":"16","author":"Fan","year":"2025","journal-title":"Front Immunol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2024.156537","article-title":"Inhibition of Hmgb1 improves experimental mice colitis by mediating Nets and macrophage polarization","volume":"176","author":"Chen","year":"2024","journal-title":"Cytokine"},{"key":"B146","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1177\/1753425916669862","article-title":"Hmgb1 exacerbates experimental mouse colitis by enhancing innate lymphoid cells 3 inflammatory responses via promoted Il-23 production","volume":"22","author":"Chen","year":"2016","journal-title":"Innate Immun"},{"key":"B147","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12974-015-0269-9","article-title":"Role of high mobility group box protein 1 (Hmgb1) in peripheral blood from patients with multiple sclerosis","volume":"12","author":"Malhotra","year":"2015","journal-title":"J Neuroinflamm"},{"key":"B148","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1177\/0961203313483377","article-title":"High mobility group box1 (Hmgb1) in relation to cutaneous inflammation in systemic lupus erythematosus (Sle)","volume":"22","author":"Abdulahad","year":"2013","journal-title":"Lupus"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1207844","article-title":"Pivotal advance: Hmgb1 expression in active lesions of human and experimental multiple sclerosis","volume":"84","author":"Andersson","year":"2008","journal-title":"J Leukoc Biol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01057","article-title":"Hmgb1 in systemic lupus erythematosus","volume":"11","author":"Liu","year":"2020","journal-title":"Front Immunol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/cei.12036","article-title":"Anti-high mobility group box 1 monoclonal antibody ameliorates experimental autoimmune encephalomyelitis","volume":"172","author":"Uzawa","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1016\/j.jid.2019.03.1148","article-title":"Oxidative stress-induced Hmgb1 release from melanocytes: A paracrine mechanism underlying the cutaneous inflammation in vitiligo","volume":"139","author":"Cui","year":"2019","journal-title":"J Invest Dermatol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1069196","article-title":"Circulatory levels of alarmins in patients with non-segmental vitiligo: Potential biomarkers for disease diagnosis and activity\/severity assessment","volume":"13","author":"He","year":"2022","journal-title":"Front Immunol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15151","article-title":"Impact of high-mobility group box 1 on melanocytic survival and its involvement in the pathogenesis of vitiligo","volume":"176","author":"Kim","year":"2017","journal-title":"Br J Dermatol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.2194","article-title":"Effect of Eritoran, an antagonist of Md2-Tlr4, on mortality in patients with severe sepsis: The Access randomized trial","volume":"309","author":"Opal","year":"2013","journal-title":"JAMA"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1997.03540430043031","article-title":"P55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. Ro 45\u20132081 Study Group","volume":"277","author":"Abraham","year":"1997","journal-title":"JAMA"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199509000-00004","article-title":"Cdp571, a humanized antibody to human tumor necrosis factor-alpha: Safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. Cpd571 Sepsis Study Group","volume":"23","author":"Dhainaut","year":"1995","journal-title":"Crit Care Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1843251\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:45:43Z","timestamp":1778215543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1843251\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":157,"alternative-id":["10.3389\/fimmu.2026.1843251"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1843251","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"article-number":"1843251"}}